WallStreetZenWallStreetZen

NASDAQ: FWBI
First Wave Biopharma Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for FWBI

Based on 1 analyst offering 12 month price targets for First Wave Biopharma Inc.
Min Forecast
$36.00+1,137.11%
Avg Forecast
$36.00+1,137.11%
Max Forecast
$36.00+1,137.11%

Should I buy or sell FWBI stock?

Based on 1 analyst offering ratings for First Wave Biopharma Inc.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their FWBI stock forecasts and price targets.

FWBI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-15

1 of 1

Forecast return on equity

Is FWBI forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.81%

Forecast return on assets

Is FWBI forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

FWBI revenue forecast

What is FWBI's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$27.5M
Avg 2 year Forecast
$58.2M
Avg 3 year Forecast
$162.2M

FWBI vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
FWBI$2.91$36.00+1,137.11%Strong Buy
PRTG$0.30$6.00+1,920.20%Buy
XBIO$3.76N/AN/A
XRTX$3.00$14.00+366.67%Strong Buy
ATXI$0.13$0.75+476.92%Strong Buy
View Top Biotech Stocks

First Wave Biopharma Stock Forecast FAQ

Is First Wave Biopharma Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: FWBI) stock is to Strong Buy FWBI stock.

Out of 1 analyst, 1 (100%) are recommending FWBI as a Strong Buy, 0 (0%) are recommending FWBI as a Buy, 0 (0%) are recommending FWBI as a Hold, 0 (0%) are recommending FWBI as a Sell, and 0 (0%) are recommending FWBI as a Strong Sell.

If you're new to stock investing, here's how to buy First Wave Biopharma stock.

What is FWBI's revenue growth forecast for 2027-2029?

(NASDAQ: FWBI) First Wave Biopharma's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.64%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.1%.

First Wave Biopharma's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast FWBI's revenue for 2027 to be $55,707,149, with the lowest FWBI revenue forecast at $55,707,149, and the highest FWBI revenue forecast at $55,707,149. On average, 1 Wall Street analysts forecast FWBI's revenue for 2028 to be $117,765,322, with the lowest FWBI revenue forecast at $117,765,322, and the highest FWBI revenue forecast at $117,765,322.

In 2029, FWBI is forecast to generate $328,487,278 in revenue, with the lowest revenue forecast at $328,487,278 and the highest revenue forecast at $328,487,278.

What is FWBI's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: FWBI) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is FWBI's Price Target?

According to 1 Wall Street analyst that have issued a 1 year FWBI price target, the average FWBI price target is $36.00, with the highest FWBI stock price forecast at $36.00 and the lowest FWBI stock price forecast at $36.00.

The Wall Street analyst predicted that First Wave Biopharma's share price could reach $36.00 by Mar 15, 2025. The average First Wave Biopharma stock price prediction forecasts a potential upside of 1,137.11% from the current FWBI share price of $2.91.

What is FWBI's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: FWBI) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.